D.O. Somers

1.6k total citations
18 papers, 1.2k citations indexed

About

D.O. Somers is a scholar working on Molecular Biology, Infectious Diseases and Virology. According to data from OpenAlex, D.O. Somers has authored 18 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Infectious Diseases and 4 papers in Virology. Recurrent topics in D.O. Somers's work include HIV/AIDS drug development and treatment (6 papers), HIV Research and Treatment (4 papers) and Biochemical and Molecular Research (4 papers). D.O. Somers is often cited by papers focused on HIV/AIDS drug development and treatment (6 papers), HIV Research and Treatment (4 papers) and Biochemical and Molecular Research (4 papers). D.O. Somers collaborates with scholars based in United Kingdom, United States and Ireland. D.O. Somers's co-authors include D.K. Stammers, E. Yvonne Jones, Elspeth F. Garman, David I. Stuart, Robert Esnouf, Carl Ross, J.N. Champness, Aniruddha Achari, Jingshan Ren and James Keeling and has published in prestigious journals such as Journal of Molecular Biology, Biochemical Journal and FEBS Letters.

In The Last Decade

D.O. Somers

18 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D.O. Somers United Kingdom 14 651 537 381 253 207 18 1.2k
Jay F. Davies United States 14 985 1.5× 616 1.1× 456 1.2× 417 1.6× 115 0.6× 17 1.7k
Pierre Bonneau Canada 24 677 1.0× 411 0.8× 257 0.7× 394 1.6× 279 1.3× 39 1.6k
Mariela Bollini Argentina 21 398 0.6× 397 0.7× 289 0.8× 435 1.7× 201 1.0× 51 1.1k
Luciano Cellai Italy 21 676 1.0× 319 0.6× 238 0.6× 215 0.8× 157 0.8× 83 1.3k
Piet Wigerinck Belgium 19 438 0.7× 1.1k 2.0× 768 2.0× 439 1.7× 421 2.0× 44 1.8k
Johnson Agniswamy United States 24 446 0.7× 745 1.4× 601 1.6× 304 1.2× 180 0.9× 55 1.3k
Henri Moereels Belgium 14 441 0.7× 437 0.8× 290 0.8× 126 0.5× 213 1.0× 29 1.2k
S. Pazhanisamy United States 14 477 0.7× 335 0.6× 305 0.8× 200 0.8× 74 0.4× 23 942
Tino W. Sanchez United States 26 682 1.0× 529 1.0× 377 1.0× 1.0k 4.1× 136 0.7× 48 2.0k
Aravind Basavapathruni United States 16 933 1.4× 341 0.6× 283 0.7× 137 0.5× 97 0.5× 25 1.4k

Countries citing papers authored by D.O. Somers

Since Specialization
Citations

This map shows the geographic impact of D.O. Somers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.O. Somers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.O. Somers more than expected).

Fields of papers citing papers by D.O. Somers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.O. Somers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.O. Somers. The network helps show where D.O. Somers may publish in the future.

Co-authorship network of co-authors of D.O. Somers

This figure shows the co-authorship network connecting the top 25 collaborators of D.O. Somers. A scholar is included among the top collaborators of D.O. Somers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.O. Somers. D.O. Somers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Barker, Michael D., John Liddle, Francis Atkinson, et al.. (2018). Discovery of potent and selective Spleen Tyrosine Kinase inhibitors for the topical treatment of inflammatory skin disease. Bioorganic & Medicinal Chemistry Letters. 28(21). 3458–3462. 18 indexed citations
2.
Borthwick, Alan D., Nicolas Ancellin, Sophie M. Bertrand, et al.. (2016). Structurally Diverse Mitochondrial Branched Chain Aminotransferase (BCATm) Leads with Varying Binding Modes Identified by Fragment Screening. Journal of Medicinal Chemistry. 59(6). 2452–2467. 27 indexed citations
3.
Carlson, Heather A., Richard D. Smith, Kelly L. Damm‐Ganamet, et al.. (2016). CSAR 2014: A Benchmark Exercise Using Unpublished Data from Pharma. Journal of Chemical Information and Modeling. 56(6). 1063–1077. 82 indexed citations
4.
Alder, Catherine M., Amanda Campbell, Angela M. Deakin, et al.. (2013). Identification of a Novel and Selective Series of Itk Inhibitors via a Template-Hopping Strategy. ACS Medicinal Chemistry Letters. 4(10). 948–952. 16 indexed citations
5.
Bamborough, Paul, Duncan S. Holmes, Katherine L. Jones, et al.. (2009). p38α Mitogen-Activated Protein Kinase Inhibitors: Optimization of a Series of Biphenylamides to Give a Molecule Suitable for Clinical Progression. Journal of Medicinal Chemistry. 52(20). 6257–6269. 35 indexed citations
6.
Angell, Richard, Paul Bamborough, Anne Cleasby, et al.. (2007). Biphenyl amide p38 kinase inhibitors 1: Discovery and binding mode. Bioorganic & Medicinal Chemistry Letters. 18(1). 318–323. 32 indexed citations
7.
Angell, Richard, Francis Atkinson, Murray J. B. Brown, et al.. (2006). N-(3-Cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amides as potent, selective, inhibitors of JNK2 and JNK3. Bioorganic & Medicinal Chemistry Letters. 17(5). 1296–1301. 70 indexed citations
8.
Slater, Martin J., Elizabeth M. Amphlett, David Andrews, et al.. (2003). Pyrrolidine-5,5-trans-lactams. 4. Incorporation of a P3/P4 Urea Leads to Potent Intracellular Inhibitors of Hepatitis C Virus NS3/4A Protease. Organic Letters. 5(24). 4627–4630. 11 indexed citations
9.
Andrews, David, Andrew C. Good, Martin R. Johnson, et al.. (2002). Pyrrolidine-5,5-trans-lactams. 2. The Use of X-ray Crystal Structure Data in the Optimization of P3 and P4 Substituents. Organic Letters. 4(25). 4479–4482. 11 indexed citations
10.
11.
Esnouf, Robert, Jingshan Ren, Elspeth F. Garman, et al.. (1998). Continuous and Discontinuous Changes in the Unit Cell of HIV-1 Reverse Transcriptase Crystals on Dehydration. Acta Crystallographica Section D Biological Crystallography. 54(5). 938–953. 44 indexed citations
12.
Achari, Aniruddha, et al.. (1997). Crystal structure of the anti-bacterial sulfonamide drug target dihydropteroate synthase. Nature Structural Biology. 4(6). 490–497. 236 indexed citations
13.
Ren, Jingshan, Robert Esnouf, Elspeth F. Garman, et al.. (1995). High resolution structures of HIV-1 RT from four RT–inhibitor complexes. Nature Structural & Molecular Biology. 2(4). 293–302. 437 indexed citations
14.
Stammers, D.K., D.O. Somers, Carl Ross, et al.. (1994). Crystals of HIV-1 Reverse Transcriptase Diffracting to 2·2 Å Resolution. Journal of Molecular Biology. 242(4). 586–588. 54 indexed citations
15.
Jones, E. Yvonne, David I. Stuart, Elspeth F. Garman, et al.. (1993). The growth and characterization of crystals of human immunodeficiency virus (HIV) reverse transcriptase. Journal of Crystal Growth. 126(2-3). 261–269. 6 indexed citations
16.
Somers, D.O., S M Medd, John E. Walker, & Margaret Adams. (1992). Sheep 6-phosphogluconate dehydrogenase. Revised protein sequence based upon the sequences of cDNA clones obtained with the polymerase chain reaction. Biochemical Journal. 288(3). 1061–1067. 17 indexed citations
17.
Somers, D.O., János Hajdu, & Margaret Adams. (1991). A two-step purification procedure for sheep liver 6-phosphogluconate dehydrogenase. Protein Expression and Purification. 2(5-6). 385–389. 3 indexed citations
18.
Adams, Margaret, et al.. (1991). The structure of 6-phosphogluconate dehydrogenase refined at 2.5 Å resolution. Acta Crystallographica Section B Structural Science. 47(5). 817–820. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jay F. Davies Breakdown of academic impact, for papers by Pierre Bonneau Breakdown of academic impact, for papers by Mariela Bollini Breakdown of academic impact, for papers by Luciano Cellai Breakdown of academic impact, for papers by Piet Wigerinck Breakdown of academic impact, for papers by Johnson Agniswamy Breakdown of academic impact, for papers by Henri Moereels Breakdown of academic impact, for papers by S. Pazhanisamy Breakdown of academic impact, for papers by Tino W. Sanchez Breakdown of academic impact, for papers by Aravind Basavapathruni
Rankless by CCL
2026